SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: Same story, different vaccine
Masoud Etemadifar, Nahad Sedaghat, Hosein Nouri, Noushin Lotfi, Ahmad Chitsaz, Reza Khorvash, Hamed Zolfaghari, Alireza Ghasemi Movaghar, Mohammad Pourabbas, Mehri Salari
Topics & Concepts
MedicineVaccinationSerologySerostatusCohortImmunologyCohort studyImmune systemLogistic regressionVirusInternal medicineAntibodyViral loadMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPeripheral Neuropathies and Disorders